Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
Sean J. Pittock(Mayo Clinic), Dean M. Wingerchuk(WinnMed), Claudia F. Lucchinetti(Mayo Clinic in Arizona), Jay Mandrekar(Mayo Clinic in Florida), Andrew McKeon(Mayo Clinic), Vanda A. Lennon(Mayo Clinic), Orna O’Toole(Beaumont Hospital), Brian G. Weinshenker(Mayo Clinic in Arizona)
Cited by 394
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k